Abstract
The effects of clorgyline were compared with the effects of (-)-deprenyl using measures of rewarding hypothalamic self-stimulation, regional monoamine metabolism and monoamine oxidase activity. Male Wistar rats trained to self-stimulate at half-maximal rates with unilateral bipolar lateral hypothalamic electrodes on a continuous reinforcement schedule were implanted subcutaneously with osmotic minipumps which delivered 1 mg·kg-1 drug per day or vehicle for 13 days. A response rate/stimulation frequency (reward summation) function was determined the day before minipump implantation and on days 5 and 13 of drug administration. Only clorgyline induced a shift to the left in the reward summation function at 5 and 13 days, indicating enhancement of reinforcement. Clonidine (50 μg·kg-1 IP) probe tests were run on days 2 and 10 to determine the sensitivity of α2-noradrenaline receptors. Clorgyline induced an attenuation of the clonidine response on day 10 relative to day 2. The other groups exhibited no change in response to clonidine. Clorgyline also induced a progressive increase in self-stimulation rates; this effect was not observed with the other groups. The clorgyline effects were accompanied by an increase in regional brain levels of dopamine, noradrenaline and 5-hydroxytryptamine and a reduction of their acid metabolites. Clorgyline selectively inhibited type A monoamine oxidase, whereas (-)-deprenyl selectively inhibited type B monoamine oxidase.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aulakh CS, Cohen RM, Pradhan SN, Murphy DL (1983) Self stimulation responses are altered following long-term but not short-term treatment with clorgyline. Brain Res 270:383–386
Aulakh CS, Cohen RM, Pradhan SN, Murphy DL (1985) Long-term desipramine treatment attenuates clonidine-induced suppression of ventral tegmental self-stimulation. Life Sci 36:443–447
Baker GB, Dewhurst WG (1985) Biochemical theories of affective disorders. In: Dewhurst WG, Baker GB (eds) Pharmacotheraphy of affective disorders. New York Univ Press, New York, NY, pp 1–59
Blier P, DeMontigny C (1985) Neurobiological basis of antidepressant treatments. In: Dewhurst WG, Baker GB (eds) Pharmacotherapy of affective disorders. New York Univ Press, New York, NY, pp 338–381
Broadbent J, Greenshaw AJ (1985) Effects of quipazine and of tryptamine on self-stimulation on median raphe nucleus and of lateral hypothalamus in rats. Pharmacol Biochem Behav 23:943–947
Cohen RM, Aulakh CS, Campbell IC, Murphy DL (1982) Functional subsensitivity of α2 adrenoceptors accompanies reductions in yohimbine binding after clorgyline treatment. Eur J Pharmacol 81:145–148
Fibiger HC, Phillips AG (1981) Increased intracranial self-stimulation in rats after long-term administration of desipramine. Science 214:683–685
Gallistel CR, Karras D (1984) Pimozide and amphetamine have opposite effects on the reward summation function. Pharmacol Biochem Behav 20:73–77
Knoll J (1976) Analysis of pharmacological effects of selective monoamine oxidase inhibitors. In: Wolstenholme GEW, Knight J (eds) Monoamine oxidase and inhibitors. Elsevier, Amsterdam, pp 135–161
König JFR, Klippel RA (1963) The rat brain: a stereotaxic atlas of the forebrain and lower parts of the brainstem. Kreiger, New York
Murphy DL, Sunderland T, Campbell I, Cohen RM (1985) Monoamine oxidase inhibitors as antidepressants. In: Dewhurst WG, Baker GB (eds) Pharmacotherapy of affective disorders. New York Univ Press, New York, NY, pp 238–261
Philips SR, Boulton AA (1979) The effect of monoamine oxidase inhibitors on some arylalkylamines in rat striatum. J Neurochem 33:159–167
Saller CF, Salama AI (1984) Rapid automated analyses of biogenic amines and their metabolites using reverse phase HPLC with electrochemical detection. J Chromatogr 309:287–298
Spyraki C, Fibiger HC (1980) Functional evidence for subsensitivity of noradrenergic α2 receptors after chronic desipramine treatment. Life Sci 27:1863–1867
Stein L (1962) Effects and interactions of imipramine, chlorpromazine, reserpine and amphetamine on self-stimulation: Possible neurophysiological basis of depression. Rec Adv Biol Psychiatry 4:288–308
Wauquier A, Clinke G, Fransen J (1981) Brain reinforcement mechanisms: alpha-adrenergic and dopamine agonists and antagonists. In: Lal H, Fielding S (eds) Psychopharmacology of clonidine. Liss, New York, NY, pp 177–196
Yu PH, Boulton AA (1979) Activation of platelet monoamine oxidase by plasma in human. Life Sci 25:31–36
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
O'Regan, D., Kwok, R.P.S., Yu, P.H. et al. A behavioural and neurochemical analysis of chronic and selective monoamine oxidase inhibition. Psychopharmacology 92, 42–47 (1987). https://doi.org/10.1007/BF00215477
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00215477